Introduction {#Sec1}
============

Myocardial bridging (MB) refers to the band of myocardium that abnormally overlies a segment of a coronary artery, which regularly (70--98%) concerns the left anterior descending artery (LAD) \[[@CR1]\]. The clinical presentation of this coronary anomaly varies widely from asymptomatic patients to those with myocardial ischemia, myocardial infarction, and even sudden death \[[@CR2]--[@CR6]\].

Until now the clinical significance of MB remains unclear. Invasive studies have revealed that patients with severe epicardial compression of the LAD-MB may show anterior wall subendocardial or transmural ischemia \[[@CR1], [@CR7], [@CR8]\]. It has also been reported that patients with mild compression of the LAD-MB may show a normal distal flow of the LAD and septal ischemia, also called "branch steal phenomenon", due to high velocity within the MB segment and changes in perfusion pressure affecting septal branches of the LAD \[[@CR9], [@CR10]\].

The existing body of research suggests that visual and physiological assessment can help explain the pathophysiology of MB. Cardiac hybrid imaging with positron emission tomography (PET)/computed tomography (CT) is a validated technique that allows anatomical and functional evaluation of the heart \[[@CR11], [@CR12]\]. It is widely accepted that low values of stress myocardial blood flow (MBF) and/or myocardial perfusion reserve (MPR) measured by PET can determine the hemodynamic significance of a stenosis, while these measurements can also assess microvascular function in the absence of epicardial stenosis \[[@CR12], [@CR13]\]. On the other hand, coronary CT angiography (CCTA) has increased the detection of MB with precise delineation of anatomical characteristics, including location, depth, length, systolic compression, and concurrent presence of atherosclerosis \[[@CR1]\].

Currently, myocardial perfusion consequences of MB are not fully understood. While it has been suggested that MB may relate to perfusion defects, only one study has reported that MB is not associated with distal abnormal stress MBF. It is unknown whether LAD-MB is related to abnormal perfusion quantifications in the entire vascular territory of the LAD or in other regions of the left ventricle. It has also been hypothesized that anatomical characteristics of a LAD-MB, especially depth and length, are related to the clinical presentation, but this remains unclear \[[@CR14]\].

This paper evaluates the influence of LAD-MB on myocardial perfusion of the entire left ventricle. There were three aims of this study: firstly, to compare global perfusion measurements of patients with and without LAD-MB; secondly, to compare regional perfusion measurements of the three vascular territories (LAD, LCx, and RCA) of patients with and without LAD-MB; thirdly, to evaluate the relationship of anatomical characteristics (length and depth) of LAD-MB, measured by CCTA, and quantitative perfusion measurements, as measured by PET.

Methods {#Sec2}
=======

Patient population and study design {#Sec3}
-----------------------------------

We retrospectively studied 131 consecutive patients between January 2010 and March 2016. All patients, suspected of coronary artery disease (CAD), were referred for ^13^N-ammonia PET myocardial perfusion imaging and CCTA, at the PET/CT Unit of the National Autonomous University of Mexico, as part of the clinical workup. MB patients were diagnosed based on their CCTA results. Exclusion criteria for both patients with and without MB were previous myocardial infarction, significant CAD (≥ 50% stenosis) detected by CCTA, non-ischemic cardiomyopathy, and/or other congenital coronary abnormalities. All patients signed an informed consent to undergo ^13^N-ammonia PET/CCTA. The institutional ethics committee approved the conduction of the study.

PET myocardial perfusion {#Sec4}
------------------------

All scans were acquired with a PET/CT scanner (Biograph True Point PET/CT 64-Multislice Scanner; Siemens Medical, Erlangen, Germany). Patients had an overnight fast and were refrained from caffeine and theophylline for 24 h before the study. Myocardial PET data were acquired at rest and during adenosine stress, as previously described \[[@CR15]\]. In brief, 10 min rest imaging acquisition started with a 740 MBq of ^13^N-ammonia i.v. injection. After 30 min, pharmacological stress was performed with an i.v. injection of adenosine during a 6-min period (140 µg/kg/min). A second dose of 740 MBq of ^13^N-ammonia was injected i.v. at the third minute of the pharmacological stress and imaging acquisition started few seconds before the radiotracer injection for a duration of 10 min. Static, dynamic, and gated datasets were obtained at rest and stress and further analyzed with automated QPET software v16 (Cedars Sinai, LA, USA) \[[@CR16]\].

An expert nuclear cardiologist (E.A.R.) analyzed the perfusion images. Dynamic data was used to perform quantification of rest and stress MBF, which are expressed in milliliter/gram/minute (ml/g/min) of myocardial tissue. Because rest MBF depends on cardiac workload, rest MBF was corrected for the rate pressure product (RPP) (rest MBF/RPP × 1000) \[[@CR17], [@CR18]\]. MPR was quantified as the ratio of absolute stress MBF to the corrected rest MBF. Rest MBF, stress MBF, and MPR were analyzed globally and regionally according to the three vascular territories using the automatic grid function "Vessels". Abnormal absolute MBF during stress with adenosine and abnormal MPR were considered as \< 1.9 ml/g/min MPR \< 2.0, respectively \[[@CR19]\]. Semi-quantification of myocardial perfusion imaging was performed on static images of the 17 segments of the heart \[[@CR20]\]. Each segment was reported as 0 = normal uptake, 1 = mildly reduced, 2 = moderate reduced, 3 = severely reduced, and 4 = absence of uptake \[[@CR15]\]. Summed scores are reported as summed stress score (SSS), summed rest score (SRS), and summed difference score (SDS) \[[@CR15]\]. An SSS ≥ 4 was considered as abnormal. Also left ventricular ejection fraction (LVEF) was assessed using gated datasets during rest and stress and analyzed automatically by the software.

Coronary computed tomography angiography {#Sec5}
----------------------------------------

CCTA scans followed the PET acquisition. Beta-blockers were administered if the heart rate was \> 65 beats per minute. Sublingual short-acting nitrates were administrated 3--4 min prior to the scan. A CCTA contrast-enhanced scan was obtained after the administration of 60--80 mL of Iopamiron 370 IV (rate 5 mL/s) during a single breath-hold (10 s). The scan was performed with the following parameters: 0.60 mm collimation, gantry rotation of 330 ms, a pitch of 0.2, X-ray tube current of 550--945 mA, and a tube voltage of 120 kVp. A non-contrast low dose radiation scan was used to determine coronary artery calcium (CAC) score. To obtain motion-free images standard multiphase prospective, electrocardiography-gated, and half-scan reconstruction windows were centered on the best cardiac phase image for analysis.

One experienced radiologist (A.M.G.) and one experienced cardiologist (E.A.B.B.) specialized in cardiovascular CCTA processed the studies using a dedicated Leonardo workstation (Siemens Medical Systems, Erlangen, Germany). CCTA raw datasets were reconstructed automatically by Syngo Via software (Siemens Medical Systems, TN, USA), as previously described \[[@CR15]\]. Global CAC was reported in Agatston Units (AU). Readers assessed the presence and the degree of coronary artery stenosis in the proximal, middle, and distal segments of the LAD, Left Circumflex Coronary Artery (LCx) and Right Coronary Artery (RCA), as well as their major branches. The presence of non-obstructive CAD is referred to the presence of \< 50% stenosis. Vessels with \< 2 mm of diameter were excluded from the analysis. MB was defined as the complete intramyocardial course of a coronary artery, including thin MB \[[@CR1]\]. MB localized at a depth of \< 2 mm and ≥ 2 mm were considered superficial and deep respectively \[[@CR14]\].

Statistical methods {#Sec6}
-------------------

Categorical variables are presented as simple proportions. Chi square and Fisher tests were used to compare proportions of variables. Parametric data were presented as the mean ± standard deviation and were compared using Student t-test. Non-parametric data were presented as the median and interquartile range (IQR) and were compared using the Mann--Whitney *U* test. Linear regression analysis was used to determine the relationship between variables. Stepwise forward selection was used to create a multiple linear regression model. We used the Spearman product-moment correlation coefficient (r) to describe the strength and direction of the correlations between continuous variables. A 2-tailed p-value ≤ 0.05 was considered statistically significant. All statistical analyses were performed using SPSS v23.

Results {#Sec7}
=======

In our population, 17 patients presented a single LAD-MB. Baseline characteristics of patients with and without LAD-MB were similar (Table [1](#Tab1){ref-type="table"}).

Table 1Baseline Characteristics of Patients with and without LAD-MBPatients with LAD-MB (n = 17)Patients without LAD-MB (n = 114)p valueAge63 ± 1160 ± 110.28Male gender7 (47)70 (63)0.27Hypertension9 (60)62 (58)0.99DM type 21 (7)18 (17)0.30Dyslipidemia7 (47)62 (58)0.42Current smoker4 (29)46 (43)0.53BMI29 ± 528 ± 50.38LVEF rest (%)67 ± 1169 ± 70.60LVEF stress (%)69 ± 1070 ± 70.81Rate pressure product in rest7857 ± 19328258 ± 19440.43Rate pressure product in stress10,302 ± 25799450 ± 25010.26Values are mean ± standard deviation, n (%)*BMI* body mass index, *DM* diabetes mellitus, *LAD* left anterior descending artery, *LVEF* left ventricular ejection fraction, *MB* myocardial bridging

Global perfusion analysis {#Sec8}
-------------------------

Global quantitative myocardial perfusion comparisons are shown in Table [2](#Tab2){ref-type="table"}. Mean global rest MBF was significantly increased in LAD-MB patients. Mean global stress MBF was similar in patients with and without LAD-MB. Mean global MPR was significantly lower in patients with a LAD-MB than in patients without MB.

Table 2Comparison of quantitative perfusion measurements between LAD-MB and patients without LAD-MBVariablePatients with LAD-MB (n = 17)Patients without LAD-MB (n = 114)p valueGlobal rest MBF (ml/g/min)1.2 ± 0.31.0 ± 0.20.002Global stress MBF (ml/g/min)2.2 ± 0.42.3 ± 0.70.42Global MPR1.9 ± 0.52.3 ± 0.60.001Values are shown as mean ± standard deviation*LAD* left anterior descending artery, *MB* myocardial bridging, *MBF* myocardial blood flow, *MPR* myocardial perfusion reserve

It was observed that the proportion of patients with an abnormal MPR (\< 2.0) was increased in LAD-MB patients \[70% (n = 12) vs. 30% (n = 34), p = 0.01\]. However, the proportion of patients with an abnormal stress MBF (\< 1.9) was similar in patients with and without an LAD-MB \[12% (n = 2) vs. 24% (n = 27), p = 0.36\]. Multiple linear regression analysis demonstrated that among cardiovascular risk factors only age and LAD-MB predicted a decrease in MPR in our study population (Table [3](#Tab3){ref-type="table"}). Multiple linear regression analysis also demonstrated that male gender, dyslipidaemia, and body mass index predicted a decrease in stress MBF in our study population (Online Resource 1).

Table 3Univariate and multiple linear regression analyses showing possible predictors of MPRUnivariate linear regression\
ß (95% CI)R^2^p valueMultiple linear regression\
ß (95% CI)p valueR^2^Age− 0.01 (− 0.02 to 0.00)0.030.040.22 (− 0.02 to − 0.001)0.030.11Male gender0.11 (− 0.12 to 0.34)0.010.33Hypertension− 0.05 (− 0.27 to 0.18)0.000.68Dyslipidaemia− 0.04 (− 0.27 to 0.19)0.000.74DM type 20.19 (− 0.10 to 0.49)0.010.200.22 (− 0.07 to 0.51)0.14Current smoker− 0.03 (− 0.18 to 0.12)0.000.68BMI− 0.01 (− 0.03 to 0.02)0.000.57LVEF in rest− 0.01 (− 0.02 to 0.01)0.000.34LVEF in stress− 0.01 (− 0.02 to 0.01)0.000.46Calcium score− 0.001 (− 0.002 to 0.001)0.010.47Presence of non-significant CAD− 0.09 (− 0.32 to 0.11)0.010.41LAD-MB− 0.49 (− 0.81 to − 0.17)0.070.003− 0.42 (− 0.75 to − 0.10)0.01Age, DM type 2, and MB are entered in the multiple linear regression model*BMI* body mass index, *CAD* coronary artery disease, *DM* diabetes mellitus, *LAD* left anterior descending artery, *LVEF* left ventricular ejection fraction, *MB* myocardial bridging

The proportion of patients with an abnormal SSS (≥ 4) was larger in patients with a MB in comparison to patients without MB \[65% (n = 11) vs. 39% (n = 45), p = 0.05\]. However, SSS did not reveal any differences between patients with and without LAD-MB \[5 (IQR 1--8) vs. 2 (IQR 0--5), p = 0.07\]. Also, SRS was similar in patients with and without LAD-MB \[0 (IQR 0--1) vs. 0 (IQR 0--1), p = 0.50\]. A significant increase in SDS was observed in patients with LAD-MB \[5 (IQR 1--7) vs. 1 (IQR 0--5), p = 0.02\].

Presence of non-significant CAD was similar in patients with and without LAD-MB \[41% (n = 7) vs. 44% (n = 50), p = 0.83\]. CAC was similar in patients with and without LAD-MB \[0 (IQR 0--16) vs. 0 (IQR 0--37), p = 0.61\].

Regional perfusion analysis {#Sec9}
---------------------------

Regional quantitative perfusion comparisons are summarized in Table [4](#Tab4){ref-type="table"}. Rest MBF was significantly increased in the three vascular territories of MB patients. Stress MBF measurements were similar in patients with and without LAD-MB in the in the three vascular territories. MPR was decreased in all three vascular territories of MB patients.

Table 4Comparison of regional quantitative perfusion measurements between LAD-MB and patients without LAD-MBVariablePatients with LAD-MB (n = 17)Patients without LAD-MB (n = 114)p valueLAD Rest MBF (ml/g/min)1.2 ± 0.31.0 ± 0.20.005 Stress MBF (ml/g/min)2.3 ± 0.52.4 ± 0.70.73 MPR2.0 ± 0.42.4 ± 0.70.001LCx Rest MBF (ml/g/min)1.3 ± 0.31.1 ± 0.30.001 Stress MBF (ml/g/min)2.3 ± 0.52.4 ± 0.70.61 MPR1.8 ± 0.42.4 ± 0.7\< 0.001RCA Rest MBF (ml/g/min)1.1 ± 0.31.0 ± 0.30.02 Stress MBF (ml/g/min)1.8 ± 0.52.1 ± 0.70.13 MPR1.7 ± 0.82.2 ± 0.70.006Values are mean ± standard deviation*LAD* left anterior descending artery, *LCx* left circumflex artery, *MB* myocardial bridging, *MBF* myocardial blood flow, *MPR* myocardial perfusion reserve, *RCA* right coronary artery

SSS was higher in the region of the LCx in patients with LAD-MB \[2 (IQR 0--5) vs. 0 (IQR 0--2), p = 0.04\]. SDS was also higher in the region of the LCx in patients with LAD-MB \[0 (IQR 0--5) vs. 0 (IQR 0--2), p = 0.01\]. Remaining regional SRS, SSS, and SDS were similar between patients with and without LAD-MB (Online Resource 2).

Presence of non-significant CAD was similar in patients with and without LAD-MB in the three coronary territories \[LAD: 35% (n = 6) vs. 22% (n = 26), p = 0.36; LCx: 29% (n = 5) vs. 39% (n = 44), p = 0.47; RCA: 29% (n = 5) vs. 27% (n = 31), p = 0.99\]. CAC was similar in patients with and without LAD-MB in the three coronary territories \[LAD: 0 (IQR 0--2) vs. 0 (IQR 0--3), p = 0.87; LCx: 0 (IQR 0--0) vs. 0 (IQR 0--0), p = 0.87; RCA: 0 (IQR 0--0) vs. 0 (IQR 0--2), p = 0.38\].

Anatomical characteristics of LAD-MB {#Sec10}
------------------------------------

Anatomical characteristics of LAD-MB are presented in the Online Resource 3. In patients with LAD-MB, we did not find a correlation between length and quantitative perfusion measurements, both global and regional (Online Resource 4). Also, global and regional rest MBF, stress MBF, and MPR were similar in patients with superficial and deep LAD-MB (Online Resource 5).

Discussion {#Sec11}
==========

The main findings of this study are that: (1) LAD-MB is related to a decreased global MPR; (2) decrease of MPR can be measured in the three coronary territories; (3) anatomical characteristics of LAD-MB did not have an effect on myocardial perfusion.

Global perfusion analysis {#Sec12}
-------------------------

This study shows that the presence of LAD-MB is related to a low MPR, an indicator of microvascular dysfunction, as a result of a high global rest MBF. In our study, patients with LAD-MB showed 17% less global MPR than patients without LAD-MB. To our knowledge, there are no previous results reporting global quantitative myocardial perfusion differences in patients with MB. A decreased MPR in the presence of high rest MBF has been reported in patients with chest pain and normal coronary arteries, hypertension, or obesity \[[@CR21], [@CR22]\]. One remaining question is whether a low MPR implies an increased cardiovascular risk in LAD-MB. A recent meta-analysis has shown that MB is related to major adverse cardiac events and ischemia, however, the stratification of patients with an MB remains a challenge \[[@CR5]\]. Meanwhile, it is well known that MPR is a marker of microvascular health in patients without obstructive coronary artery disease \[[@CR23]\]. Gupta et al. reported that a reduced MPR, even in the presence of normal stress MBF and a high rest MBF, is linked to adverse outcomes \[[@CR24]\]. Therefore, it is possible that MPR measured by PET may help to identify MB patients that have an increased cardiovascular risk due to microvascular dysfunction. However, prospective studies are needed to confirm our results in a larger population and to determine the prognostic value of stress MBF and MPR in patients with MB.

Regional perfusion analysis {#Sec13}
---------------------------

In the presence of LAD-MB, we found that the decrease of MPR in the three vascular territories (LAD, LCx, and RCA) is related to an increased rest MBF rather than to a decreased stress MBF. These results indicate that the presence of a LAD-MB may coexist with a state of microvascular dysfunction of the left ventricle, which might explain why myocardial perfusion defects, including those in the anterior, lateral and inferior walls, are more common in patients with LAD-MB (Fig. [1](#Fig1){ref-type="fig"}) \[[@CR25], [@CR26]\]. Interestingly, we did not find an increase of perfusion defects in the LAD territory that indicate anterior or septal ischemia in patients with a LAD-MB, as suggested before \[[@CR9]\]. Our results support that the decreased of MPR in patients with LAD-MB is not the result of a flow-limiting significance of the MB since stress MBF, which is an accurate parameter of stenosis, was similar in patients with and without LAD-MB \[[@CR27]\]. Similar to our study, Uusitalo et al. first reported the relation between MB and absolute rest and stress MBF in the distal segments affected by an MB of any coronary artery, using adenosine stress and Oxygen-15 water PET, without finding any decreased stress MBF in the MB affected territory \[[@CR28]\]. Because of heterogeneity of methodology and results in previous studies, which mostly focus on one coronary territory, we suggest that global and regional quantitative assessment of the three vascular territories could help better to understand the clinical presentation of MB.

Fig. 1**a, b** CCTA demonstrated a LAD-MB (*white arrows*) and no coronary artery disease in the LAD, LCx, nor RCA. **c** Dynamic polar map of ^13^N-ammonia PET shows low global MPR (\< 2.0) and low global stress MBF (\< 1.9 ml/g/min). **d** Myocardial perfusion imaging showed apical and inferolateral mild ischemia (*white arrows*)

Anatomical characteristics of LAD-MB {#Sec14}
------------------------------------

Our study did not show differences in perfusion quantifications in patients with a deep and superficial LAD-MB. Also, the length of LAD-MB did not correlate with myocardial perfusion quantifications. However, with a small sample size, caution must be applied, as possibility remains that other findings could influence hemodynamics, such as the location of MB in the segment of the LAD and diameter of stenosis \[[@CR10], [@CR29]\]. In this setting, dobutamine stress might play an important role in determining the significance of LAD-MB by better delineating the severity of MB compression. Therefore, further work could still establish a relationship between quantitative myocardial perfusion and MB anatomical characteristics including precise location, length, depth, and compression of an MB.

Study limitations {#Sec15}
-----------------

Our study has some limitations due to its retrospective nature. We studied a discrete population of patients with LAD-MB, however, similar prevalence has been previously reported \[[@CR2]\]. Furthermore, because we studied patients with suspected CAD, we cannot extrapolate our results to asymptomatic subjects. Another limitation is that we were not able to fully analyze the hemodynamic severity of compression of the intramyocardial segments produced during systole due to a prospective triggering of the CCTA and an adenosine stress \[[@CR2], [@CR10]\].

Conclusions {#Sec16}
===========

In our study, quantitative perfusion assessment by PET suggests that LAD-MB may be related to impaired perfusion reserve, an indicator of microvascular dysfunction. Anatomical characteristics of LAD-MB were not related to changes in myocardial perfusion. Global and regional quantitative myocardial perfusion assessment is a promising tool that may help to better understand the clinical significance of LAD-MB and to identify patients who may benefit from further therapies. Prospective studies are needed to confirm our results and to determine the prognostic value of stress MBF and MPR in patients with MB.
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